OncoDNA has raised $8.6 million to develop IT platforms to support its oncology testing operation.

Repositive has introduced the full version of its online genomics data platform, which features 23 times as many data sets as the beta iteration.

Researchers have published the first analysis of the 60,000 people sequenced through the Exome Aggregation Consortium.

The Pfizer study that identified 15 genome sites linked to depression in 23andMe’s database has sparked a surge in demands to access the repository.

Researchers at MIT have developed a framework to ensure genetic data can be shared freely without putting individuals’ privacy at risk.

Illumina has tasked FlowJo with developing data analysis software to support its expansion into high-throughput sequencing of single cells.

Pfizer has delivered a clear indication of the research potential of 23andMe’s massive database by finding 15 genetic loci linked to risk of major depression.

Researchers at the U.S. National Institutes of Health have led the development of software to identify sequence-structure binding motifs on aptamers.